Application Search

Applications can be searched from keywords such as compound name, field, column, etc.
It is also useful for selecting appropriate analytical columns.

Application Search

New Applications

LC038 - Analysis of Brilliant Green and Methylene Blue -

LC InertSearch InertSustain C18
LC037 - Analysis of Amlodipine Besilate (Under the Condition of the Japanese Pharmacopoeia 18th, Amlodipine Besilate, Purity(2) Related Substances) -

LC InertSearch InertSustain C18
LC036 - Analysis of Zonisamide (Under the Condition of USP41-NF36, Zonisamide Compounded Oral Suspension, ASSAY) -

LC InertSearch InertSustain C18
LC035 - Analysis of Zonisamide (Under the Condition of USP43-NF38, Zonisamide Capsules, ASSAY) -

LC InertSearch InertSustain C18
LC034 - Analysis of Zonisamide (Under the Condition of USP43-NF38, Zonisamide, ASSAY) -

LC InertSearch InertSustain C18
MA090 - Analysis of Hydrocarbons C5-C10 -

Micro GC InertSearch
MA089 - Analysis of Hydrocarbons C2-C4 -

Micro GC InertSearch
MA088 - Analysis of Organic acids(Formic acid, Acetic acid) -

Micro GC InertSearch
MA087 - Analysis of Organic solvents(Methanol, Ethanol, Acetone) -

Micro GC InertSearch
MA086 - Analysis of Carbon dioxide -

Micro GC InertSearch
MA085 - Analysis of Carbon dioxide -

Micro GC InertSearch
MA084 - Analysis of Carbon dioxide -

Micro GC InertSearch
LC033 - Analysis of D‐Biotin (Under the Condition of USP43-NF38, Oil- and Water-Soluble Vitamins Minerals Tablets,BIOTIN_Method 3) -

LC InertSearch InertSustain C18
LC032 - Analysis of D‐Biotin (Under the Condition of USP4１-NF3６, Oil- and Water-Soluble Vitamins Capsules,BIOTIN_Method 1) -

LC InertSearch InertSustain C8
LC031 - Analysis of D‐Biotin (Under the Condition of USP43-NF38, Biotin) -

LC InertSearch InertSustain C8
LC030 - Analysis of Piperazine anhydrous -

LC InertSearch InertSustain Amide
LC029 - Analysis of Riboflavin (Under the Condition of USP41-NF36, Oil- and Water-Soluble Vitamins Capsules,RIBOFLAVIN_Method 2) -

LC InertSearch InertSustain C18
LC028 - Analysis of Pyridoxine hydrochloride (Under the Condition of USP41-NF36, Oil- and Water-Soluble Vitamins Capsules,PYRIDOXINE HYDROCHLORIDE_Method 2) -

LC InertSearch InertSustain C18
LC027 - Analysis of Nicotinamide (Under the Condition of USP41-NF36, Oil- and Water-Soluble Vitamins Capsules,NIACINAMIDE_Method 2) -

LC InertSearch InertSustain C18
LC026 - Analysis of Nicotinic acid (Under the Condition of USP41-NF36, Oil- and Water-Soluble Vitamins Capsules,Niacin_Method 2) -

LC InertSearch InertSustain C18
LC025 - Analysis of Eplerenone (Under the Condition of draft for USP, Eplerenone Tablets, ASSAY) -

LC InertSearch InertSustain AQ-C18
LC024 - Analysis of Eplerenone (Under the Condition of draft for USP, Eplerenone, ASSAY) -

LC InertSearch Inertsil ODS-3
LC023 - Analysis of Lansoprazole (Under the Condition of the USP41-NF36, Lansoprazole Compounded Oral Suspension, ASSAY) -

LC InertSearch InertSustain C18
LC022 - Analysis of Ursodeoxycholic acid (Under the Condition of the Japanese Pharmacopoeia 18th, Ursodeoxycholic acid Tablets, Ursodeoxycholic acid Granules) -

LC InertSearch InertSustain C18
LC021 - Analysis of Cyanocobalamin (Under the Condition of USP4１-NF3６, Oil- and Water-Soluble Vitamins Capsules,Cyanocobalamin_Method1) -

LC InertSearch Inertsil ODS-HL
LC020 - Analysis of D(-)-Mannitol -

LC InertSearch InertSphere FA-1
LC019 - Analysis of Aspartame and L-α-Aspartyl-D-phenylalanine Methyl Ester -

LC InertSearch InertSustain C18
LC018 - Analysis of L-α-Aspartyl-D-phenylalanine Methyl Ester (Japan’s Standards and Specifications for Food Additives (10th ed.), Aspartame, Purity(5)) -

LC InertSearch InertSustain C18
LC017 - Analysis of Itraconazole (Under the Condition of Japanese Pharmacopoeia 18th, Itraconazole, Purity(2) Related substances) -

LC InertSearch InertSustain C18
LC016 - Analysis of Itraconazole (Under the Condition of USP-NF 2021 Issue 2, Itraconazole Capsules, ASSAY) -

LC InertSearch InertSustain C18
LC015 - Analysis of Itraconazole (Under the draft for USP, Itraconazole Oral Solution, ASSAY) -

LC InertSearch InertSustain C18
LC014 - Analysis of Itraconazole (Under the Condition of USP43-NF38, Itraconazole, ASSAY) -

LC InertSearch InertSustainSwift C18
LC013 - Analysis of Bleomycin sulfate -

LC InertSearch InertSustain AQ-C18
LC012 - Analysis of Ethanol and Acetonitrile (Under the Condition for the Draft for USP, Tavaborole Topical Solution, Content of Alcohol) -

LC InertSearch Inertsil NH2
LC011 - Analysis of Spectinomycin -

LC InertSearch InertSustain C8
GA387 - Analysis of Ethanol and Acetonitrile (Under the Condition for the Draft for USP, Tavaborole Topical Solution, Content of Alcohol) -

GC InertSearch InertCap FFAP
LC010 - Analysis of Imazalil (Under the Condition of food additive analysis method in food, Imazalil) -

LC InertSearch Inertsil ODS-3
LC009 - Analysis of Ketotifen Fumarate (Under the Condition of USP-NF 2024 Issue 3, Ketotifen Fumarate, ASSAY) -

LC InertSearch Inertsil ODS-3
LC008 - Analysis of Ketotifen Fumarate (Under the Condition of USP-NF 2024 Issue 3, Ketotifen Fumarate, ASSAY) -

LC InertSearch InertSustain C18
LC007 - Analysis of Olanzapine -

LC InertSearch InertSustain C8
LC006 - Analysis of Benzoyl Peroxide（Under the Condition of food additive analysis method in food, Benzoyl peroxide) -

LC InertSearch Inertsil ODS-3
GA386 - Analysis of Fatty acid methyl ester -

GC InertSearch InertCap Pure-WAX
GA385 - Analysis of Palmitic acid and 2-Ethylhexanoic acid -

GC InertSearch InertCap FFAP
LC005 - Carbamazepine -

LC InertSearch InertSustainSwift C18
GA384 - 1,2-Octanediol -

GC InertSearch InertCap 17

Application Search

Application Search

New Applications

LC038 - Analysis of Brilliant Green and Methylene Blue -

LC037 - Analysis of Amlodipine Besilate (Under the Condition of the Japanese Pharmacopoeia 18th, Amlodipine Besilate, Purity(2) Related Substances) -

LC036 - Analysis of Zonisamide (Under the Condition of USP41-NF36, Zonisamide Compounded Oral Suspension, ASSAY) -

LC035 - Analysis of Zonisamide (Under the Condition of USP43-NF38, Zonisamide Capsules, ASSAY) -

LC034 - Analysis of Zonisamide (Under the Condition of USP43-NF38, Zonisamide, ASSAY) -

MA090 - Analysis of Hydrocarbons C5-C10 -

MA089 - Analysis of Hydrocarbons C2-C4 -

MA088 - Analysis of Organic acids(Formic acid, Acetic acid) -

MA087 - Analysis of Organic solvents(Methanol, Ethanol, Acetone) -

MA086 - Analysis of Carbon dioxide -

MA085 - Analysis of Carbon dioxide -

MA084 - Analysis of Carbon dioxide -

LC033 - Analysis of D‐Biotin (Under the Condition of USP43-NF38, Oil- and Water-Soluble Vitamins Minerals Tablets,BIOTIN_Method 3) -

LC032 - Analysis of D‐Biotin (Under the Condition of USP4１-NF3６, Oil- and Water-Soluble Vitamins Capsules,BIOTIN_Method 1) -

LC031 - Analysis of D‐Biotin (Under the Condition of USP43-NF38, Biotin) -

LC030 - Analysis of Piperazine anhydrous -

LC029 - Analysis of Riboflavin (Under the Condition of USP41-NF36, Oil- and Water-Soluble Vitamins Capsules,RIBOFLAVIN_Method 2) -

LC028 - Analysis of Pyridoxine hydrochloride (Under the Condition of USP41-NF36, Oil- and Water-Soluble Vitamins Capsules,PYRIDOXINE HYDROCHLORIDE_Method 2) -

LC027 - Analysis of Nicotinamide (Under the Condition of USP41-NF36, Oil- and Water-Soluble Vitamins Capsules,NIACINAMIDE_Method 2) -

LC026 - Analysis of Nicotinic acid (Under the Condition of USP41-NF36, Oil- and Water-Soluble Vitamins Capsules,Niacin_Method 2) -

LC025 - Analysis of Eplerenone (Under the Condition of draft for USP, Eplerenone Tablets, ASSAY) -

LC024 - Analysis of Eplerenone (Under the Condition of draft for USP, Eplerenone, ASSAY) -

LC023 - Analysis of Lansoprazole (Under the Condition of the USP41-NF36, Lansoprazole Compounded Oral Suspension, ASSAY) -

LC022 - Analysis of Ursodeoxycholic acid (Under the Condition of the Japanese Pharmacopoeia 18th, Ursodeoxycholic acid Tablets, Ursodeoxycholic acid Granules) -

LC021 - Analysis of Cyanocobalamin (Under the Condition of USP4１-NF3６, Oil- and Water-Soluble Vitamins Capsules,Cyanocobalamin_Method1) -

LC020 - Analysis of D(-)-Mannitol -

LC019 - Analysis of Aspartame and L-α-Aspartyl-D-phenylalanine Methyl Ester -

LC018 - Analysis of L-α-Aspartyl-D-phenylalanine Methyl Ester (Japan’s Standards and Specifications for Food Additives (10th ed.), Aspartame, Purity(5)) -

LC017 - Analysis of Itraconazole (Under the Condition of Japanese Pharmacopoeia 18th, Itraconazole, Purity(2) Related substances) -

LC016 - Analysis of Itraconazole (Under the Condition of USP-NF 2021 Issue 2, Itraconazole Capsules, ASSAY) -

LC015 - Analysis of Itraconazole (Under the draft for USP, Itraconazole Oral Solution, ASSAY) -

LC014 - Analysis of Itraconazole (Under the Condition of USP43-NF38, Itraconazole, ASSAY) -

LC013 - Analysis of Bleomycin sulfate -

LC012 - Analysis of Ethanol and Acetonitrile (Under the Condition for the Draft for USP, Tavaborole Topical Solution, Content of Alcohol) -

LC011 - Analysis of Spectinomycin -

GA387 - Analysis of Ethanol and Acetonitrile (Under the Condition for the Draft for USP, Tavaborole Topical Solution, Content of Alcohol) -

LC010 - Analysis of Imazalil (Under the Condition of food additive analysis method in food, Imazalil) -

LC009 - Analysis of Ketotifen Fumarate (Under the Condition of USP-NF 2024 Issue 3, Ketotifen Fumarate, ASSAY) -

LC008 - Analysis of Ketotifen Fumarate (Under the Condition of USP-NF 2024 Issue 3, Ketotifen Fumarate, ASSAY) -

LC007 - Analysis of Olanzapine -

LC006 - Analysis of Benzoyl Peroxide（Under the Condition of food additive analysis method in food, Benzoyl peroxide) -

GA386 - Analysis of Fatty acid methyl ester -

GA385 - Analysis of Palmitic acid and 2-Ethylhexanoic acid -

LC005 - Carbamazepine -

GA384 - 1,2-Octanediol -

Solution Category